Previous 10 | Next 10 |
Aclaris Therapeutics, Inc. (ACRS) Q4 2019 Earnings Conference Call February 25, 2020, 05:00 PM ET Company Participants Kamil Ali-Jackson - Chief Legal Officer Neal Walker - President and CEO Frank Ruffo - CFO David Gordon - Chief Medical Officer Joe Monahan - EVP, Research an...
Penny Stocks To Watch After Coronavirus Comments This topic continues to captivate headlines: the coronavirus. A number of penny stocks have greatly benefited from speculation on “what’s next” for the virus spread. Today may have opened a bigger can of worms for investor...
Aclaris Therapeutics (NASDAQ: ACRS ): Q4 GAAP EPS of -$0.45 misses by $0.30 . More news on: Aclaris Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Positive Preliminary Results from Phase 1 Single and Multiple Ascending Dose Trial of ATI-450, an Investigational Oral MK2 Inhibitor Projected Cash Runway into the Third Quarter of 2021 Management to Host Conference Call at 5:00 PM ET today WAYNE, Pa., Feb. 25, 2020 (GLOBE...
WAYNE, Pa., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS) a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced it will report financial results for the fourth quarter and full year 2019, Tuesday, February 25 th , af...
AIM ImmunoTech (NYSEMKT: AIM ) +20% on discussing the potential role of Ampligen for use against the Wuhan 2019 Novel Coronavirus. More news on: AIM ImmunoTech Inc., TransEnterix, Inc., Shopify Inc., Stocks on the move, , Read more ...
WAYNE, Pa., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that management will present a company overview at the SVB Leerink 9th Annual Global Healthcare Confere...
Acasti Pharma (NASDAQ: ACST ) -66% after unsuccessful results from a Phase 3 TRILOGY 1 trial. More news on: Acasti Pharma Inc., Stage Stores, Inc., Five Below, Inc., Stocks on the move, Read more ...
Sorrento Therapeutics (NASDAQ: SRNE ) +50% on non-binding takeover bid . More news on: Sorrento Therapeutics, Inc., Aclaris Therapeutics, Inc., AzurRx BioPharma, Inc., Stocks on the move, Read more ...
Are These Penny Stocks On Your Friday Morning Watch List? Friday, January 10 marks the end of the first full week of 2020 and there are several economic reports to take into account. These include employment, nonfarm payrolls, and business inventories. These will all be reported throughout the...
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities - - $26.5 Million Upfront Plus Up to $5.0 Million Milestone - WAYNE, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company ...
WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will part...
- Progressing ATI-2138 into Atopic Dermatitis - - Management to Host Conference Call at 5:00 PM ET Today - WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidat...